Aseel AlSaleh, Waqar Husain, Khaled Trabelsi, Hadeel Ghazzawi, Achraf Ammar, Zahra Saif, Seithikurippu R Pandi-Perumal, Maha M AlRasheed, Ahmed S BaHammam, Haitham Jahrami
{"title":"Pre-Sleep Arousal Scale (PSAS): Translation and Evaluation of Its Psychometric Properties in an Arabic Version.","authors":"Aseel AlSaleh, Waqar Husain, Khaled Trabelsi, Hadeel Ghazzawi, Achraf Ammar, Zahra Saif, Seithikurippu R Pandi-Perumal, Maha M AlRasheed, Ahmed S BaHammam, Haitham Jahrami","doi":"10.2147/NSS.S490206","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The Pre-Sleep Arousal Scale (PSAS) is a well-recognized instrument utilized for measuring cognitive and somatic arousal before sleep. Although the PSAS is useful, an Arabic version of the scale has not yet been developed and validated. The current study aimed to translate the PSAS into Arabic language and evaluate its psychometric properties, such as reliability and validity, in an Arabic-speaking population.</p><p><strong>Patients and methods: </strong>A cross-sectional survey was conducted with 438 participants who completed the Arabic version of the PSAS, along with other validated measures of insomnia, anxiety, and sleep effort.</p><p><strong>Results: </strong>The results indicated that the Arabic version of the PSAS maintained the original scale's two-factor structure. The factor loadings for PSAS-Cognitive ranged from 0.57 to 0.75, and for PSAS-Somatic, from 0.45 to 0.70, with all loadings being statistically significant (<i>p</i> < 0.001). The Arabic version of the PSAS exhibited high internal consistency (McDonald's <i>ω</i> = 0.86; Cronbach's <i>α</i> = 0.86; Guttman's <i>λ</i>2 = 0.86; Greatest Lower Boun<i>d</i> = 0.90) and test-retest reliability (ICC = 0.88) over two weeks. The PSAS demonstrated good concurrent and convergent validity. We documented significant large differences between individuals with \"no insomnia\" and those with \"insomnia\" symptoms across cognitive, somatic, and total pre-sleep arousal (all <i>p</i> <0.001). The insomnia group consistently scored higher scores for PSAP and its subscales.</p><p><strong>Conclusion: </strong>These findings suggest that the Arabic version of the PSAS is a reliable and valid tool for assessing pre-sleep arousal in Arabic-speaking individuals.</p>","PeriodicalId":18896,"journal":{"name":"Nature and Science of Sleep","volume":"16 ","pages":"1725-1735"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520919/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature and Science of Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NSS.S490206","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The Pre-Sleep Arousal Scale (PSAS) is a well-recognized instrument utilized for measuring cognitive and somatic arousal before sleep. Although the PSAS is useful, an Arabic version of the scale has not yet been developed and validated. The current study aimed to translate the PSAS into Arabic language and evaluate its psychometric properties, such as reliability and validity, in an Arabic-speaking population.
Patients and methods: A cross-sectional survey was conducted with 438 participants who completed the Arabic version of the PSAS, along with other validated measures of insomnia, anxiety, and sleep effort.
Results: The results indicated that the Arabic version of the PSAS maintained the original scale's two-factor structure. The factor loadings for PSAS-Cognitive ranged from 0.57 to 0.75, and for PSAS-Somatic, from 0.45 to 0.70, with all loadings being statistically significant (p < 0.001). The Arabic version of the PSAS exhibited high internal consistency (McDonald's ω = 0.86; Cronbach's α = 0.86; Guttman's λ2 = 0.86; Greatest Lower Bound = 0.90) and test-retest reliability (ICC = 0.88) over two weeks. The PSAS demonstrated good concurrent and convergent validity. We documented significant large differences between individuals with "no insomnia" and those with "insomnia" symptoms across cognitive, somatic, and total pre-sleep arousal (all p <0.001). The insomnia group consistently scored higher scores for PSAP and its subscales.
Conclusion: These findings suggest that the Arabic version of the PSAS is a reliable and valid tool for assessing pre-sleep arousal in Arabic-speaking individuals.
期刊介绍:
Nature and Science of Sleep is an international, peer-reviewed, open access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.
Specific topics covered in the journal include:
The functions of sleep in humans and other animals
Physiological and neurophysiological changes with sleep
The genetics of sleep and sleep differences
The neurotransmitters, receptors and pathways involved in controlling both sleep and wakefulness
Behavioral and pharmacological interventions aimed at improving sleep, and improving wakefulness
Sleep changes with development and with age
Sleep and reproduction (e.g., changes across the menstrual cycle, with pregnancy and menopause)
The science and nature of dreams
Sleep disorders
Impact of sleep and sleep disorders on health, daytime function and quality of life
Sleep problems secondary to clinical disorders
Interaction of society with sleep (e.g., consequences of shift work, occupational health, public health)
The microbiome and sleep
Chronotherapy
Impact of circadian rhythms on sleep, physiology, cognition and health
Mechanisms controlling circadian rhythms, centrally and peripherally
Impact of circadian rhythm disruptions (including night shift work, jet lag and social jet lag) on sleep, physiology, cognition and health
Behavioral and pharmacological interventions aimed at reducing adverse effects of circadian-related sleep disruption
Assessment of technologies and biomarkers for measuring sleep and/or circadian rhythms
Epigenetic markers of sleep or circadian disruption.